Search - tctmd.com

Displaying 81 - 100 of 341

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

L.A. McKeown

September 12, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Conference News SCAI 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

L.A. McKeown

May 21, 2023

Presentation Fellows 2023

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Presenter: Jay Giri

May 12, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Conference News ISET 2023

‘Who’s In Charge of a Wound?’: Interventionalists Should Play a Role

Caitlin E. Cox

January 18, 2023

News Daily News

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Caitlin E. Cox

December 30, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

Presentation TCT 2022

How Do I Choose DVTs to Intervene Upon?

Presenter: Jon George

September 19, 2022

Presentation TCT 2022

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

Presentation TCT 2022

Clinical RV Assessment in PE: Is it Hocus Pocus or Can We Standardize Echo Parameters?

Presenter: Rebecca Hahn

September 19, 2022

Presentation TCT 2022

Hemodynamics of PE: Modeling the RV

Presenter: Daniel Burkhoff

September 19, 2022

Advertisement

October 2023 News Roundup

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

‘Who’s In Charge of a Wound?’: Interventionalists Should Play a Role

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

How Do I Choose DVTs to Intervene Upon?

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

State-of-the-Art Lecture: Future Device Therapies in PE

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Clinical RV Assessment in PE: Is it Hocus Pocus or Can We Standardize Echo Parameters?

Hemodynamics of PE: Modeling the RV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content